Uzm. Dr. İsmail Yıldız

Endokrinoloji ve Metabolizma Hastalıkları

  • Doğum Tarihi:
  • Yabancı Dil: İngilizce, Arapça

Hekim Özgeçmişi

Mezun Olduğu Tıp Fakültesi ve Yılı

İstanbul Üniversitesi, İstanbul Tıp Fakültesi, 2010

Uzmanlık Eğitimi Aldığı Yer ve Yılı
  • İstanbul Eğitim ve Araştırma Hastanesi, İç Hastalıkları Uzmanlığı, 2015
  • Mersin Üniversitesi Tıp Fakültesi ve Tekirdağ Namık Kemal Üniversitesi Tıp Fakültesi, Endokrinoloji Yan Dal Uzmanlığı, 2016-2019
Mezuniyet Sonrası Görevler
  • Çorlu Devlet Hastanesi, 2019-2021
  • Özel Muayenehane, 2021-2023
  • Özel Reyap Hastanesi İstanbul ve Çorlu, 2023-Halen
Bilimsel Çalışmalar

Yayınlar

  • The effect of gender on response to antithyroid drugs and risk of relapse after discontinuation of the antithyroid drugs in patients with Graves’ hyperthyroidism: a multicentre study,. 2020;71(3):207-212. doi: 10.5603/EP.a2020.0007. Epub 2020 Mar 10.
  • External Validation of the GREAT Score in Turkish Patients with Graves’ Hyperthyroidism Treated withthe Titration Regimen Method of Antithyroid Drugs: A Multicenter Study. 2019 Oct;51(10):627-633. doi: 10.1055/a-0974-3991.Epub 2019 Sep 9.
  • Janus kinase 2 mutations in cases with BCR-ABLnegative chronic myeloproliferative disorders from Turkey. Ismail Yildiz, Osman Yokuş, and Habip Gedik. ; 7(1): 2831. doi: 10.4103/2231-0770.197511
  • A Localized Painful Rash Induced by Linagliptin in a Patient with type 2 Diabetes DOI: 10.4274/imj.galenos.2018.75735
  • Amiodarone induced thyrotoxicosis may not respond to therapeutic plasma exchange like patients with graves disease: A report of two cases and literature review https://doi.org/10.5455/medscience.2018.07.8954
  • The frequency of Cushings disease, ACTH-independent Cushings syndrome and autonomous cortisol secretion among Turkish patients with obesity doi: 10.14744/nci.2019.54771
This site is registered on wpml.org as a development site.